AHG - CIK 0001702318
The table below shows Akso Health Group's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $1.18M | $1.35M | -$3.25M | -$8.63M | $10.06M | -$58.28M |
| Capital expenditure | $154.46K | - | - | - | - | - |
| Investing cash flow | -$105.91M | -$54.72M | $18.47M | -$19.96M | -$662.00 | $12.78M |
| Dividends paid | - | - | - | - | - | - |
Akso Health Group reported operating cash flow of $1.18M for fiscal year 2025. That is down 12.9% from $1.35M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $7.03M (FY 2016) to $1.18M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | $2.67M |
| Financing cash flow | $195.88M | $131.65M | -$27.51M | $34.78M | -$9.04M | -$1.55M |